image description

Reach the children most at risk with the LeadCare® II point-of-care test.

Tackle health disparities early.

Forty percent of families served by federal health programs, such as Medicaid and WIC, do not follow through with prescribed blood lead testing at a reference lab.  Yet the prevalence of elevated blood lead for these children is 5 times higher than the general population1.

Point-of-care testing with the LeadCare II provides an immediate
opportunity to treat and educate, minimizing the health and learning
problems that come from lead exposure.  

LeadCare II Benefits

image description

Point-of-care test

1 fingerstick,2 drops of blood. Combines with hemoglobin /anemia testing

image description

Results in 3 minutes

Immediate education & intervention, no one lost to follow up.

image description

Portable

Easily incorporates with offsite clinics & non-traditional settings.

image description

Reach those at risk

Increase screening rates without adding resources.

Point-of-care testing reaches those at risk, eliminating need for follow up.

Rapid results mean you can educate and begin intervention immediately, while parents are still in your clinic. LeadCare II’s accurate result empowers parents and communities to act without delay.

Over 535,000 children in the U.S. have harmful blood lead levels.2  Have these children in your community been identified?

Who should be tested?

Federal law requires that all Medicaid eligible children be tested at 12 and 24 months and ages 36 to 72 months if they have not previously been tested.

Each state has guidelines for blood lead testing.  The American Academy of Pediatrics (AAP) recommends that “children should be tested at least once when they are 2 years of age or, ideally, twice, at 1 and 2 years of age, unless lead exposure can be confidently excluded.3

Who is at risk for lead exposure?  Children are considered at risk if any of the following are true4:

  • Child lives in or frequently visits a home built before 1950, or a recently renovated home built before 1978.
  • Child has a sibling or frequent playmate with elevated blood lead levels.
  • Child’s parent or primary caregiver works with lead. Examples include: battery recycling or manufacture, lead smelting, lead mining, auto repair, shipbuilding, construction, plumbing, and glass manufacture.5
  • Child is a recent immigrant, refugee, or foreign adoptee.
  • Child has a household member who uses traditional, folk, or ethnic remedies or cosmetics or who routinely eats food imported informally (e.g., by a family member).

The LeadCare II System was developed with the Centers for Disease Control and Prevention (CDC) so children can be screened for lead wherever they already receive healthcare or services.  It is the only CLIA-waived point-of-care blood lead testing system.

Accurate, early diagnosis is crucial so that children can be treated to prevent serious health and learning consequences. Blood lead testing also guides lead remediation and enforcement actions to eliminate lead contamination in housing, consumer products, and the environment.

No safe levels. Evidence continues to grow that even low blood lead levels may affect learning.  Elevated blood lead levels have been associated with avoidable special education costs of $3,331 per child and a decrease in lifetime earnings.6

To learn more or to discuss how LeadCare II can help you improve screening rates in the communities you serve, contact us.

  1. U.S. General Accounting Office. Lead Poisoning: Federal Healthcare Programs Are Not Effectively Reaching At-Risk Children, GAO/HEHS-99-18, Washington, DC, Jan. 1999. www.gao.gov/archive/1999/he99018.pdf. Accessed Jan 2012.
  2. Wheeler, W. Blood Lead Levels in Children aged 1-5 years - US, 199-2010. Morbidity and Mortality Weekly Report. 2013;62(13):245-247.
  3. American Academy of Pediatrics, Committee on Environmental Health. Lead Exposure in Children:  Prevention, Detection, and Management. Policy Statement. Pediatrics. 2005; 116:1036-1046. Affirmed Jan 2009.
  4. Wengrovitz AM, Brown, MJ. Recommendations for Blood Lead Screening of Medicaid-Eligible Children Aged 1-5 Years: an Updated Approach to Targeting A Group at High Risk.  Morbidity and Mortality Weekly Report. August, 7, 2009; 58(RR09) 6. http://www.cdc.gov/mmwr/pdf/rr/rr5809.pdf. Accessed Jan 2012.
  5. Lead Toxicity: Who is at Risk of Lead Exposure? CDC’s Agency for Toxic Substances and Disease Registry Case Studies in Environmental Medicine (CSEM). www.atsdr.cdc.gov/csem/lead/docs/lead.pdf. Accessed Jan 2012. 
  6. U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality, National Quality Measures Clearinghouse. Lead Screening in Children:  percentage of children two years of age who had one or more capillary or venous lead blood tests for lead poisoning by their second birthday. 2010. http://qualitymeasures.ahrq.gov/content.aspx?id=32464. Accessed Jan 2012.

Success Stories

Point-of-Care Lead Testing on a Mobile Medical Unit: What a Concept!

"...We have improved ability to follow-up and parents' willingness to follow through." notes Persharon M. Dixon, MD, FAAP, Medical Director
More Success Stories

Request More Information
* = Required

 Security code